Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

被引:536
作者
Heath, WR [1 ]
Belz, GT
Behrens, GMN
Smith, CM
Forehan, SP
Parish, IA
Davey, GM
Wilson, NS
Carbone, FR
Villadangos, JA
机构
[1] Walter & Eliza Hall Inst Med Res, Dept Immunol, Melbourne, Vic 3050, Australia
[2] Walter & Eliza Hall Inst Med Res, Cooperat Res Ctr Vaccine Technol, Melbourne, Vic 3050, Australia
[3] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia
关键词
D O I
10.1111/j.0105-2896.2004.00142.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cross-presentation involves the uptake and processing of exogenous antigens within the major histocompatibility complex (MHC) class I pathway. This process is primarily performed by dendritic cells (DCs), which are not a single cell type but may be divided into several distinct subsets. Those expressing CD8alpha together with CD205, found primarily in the T-cell areas of the spleen and lymph nodes, are the major subset responsible for cross-presenting cellular antigens. This ability is likely to be important for the generation of cytotoxic T-cell immunity to a variety of antigens, particularly those associated with viral infection, tumorigenesis, and DNA vaccination. At present, it is unclear whether the CD8alpha-expressing DC subset captures antigen directly from target cells or obtains it indirectly from intermediary DCs that traffic from peripheral sites. In this review, we examine the molecular basis for cross-presentation, discuss the role of DC subsets, and examine the contribution of this process to immunity, with some emphasis on DNA vaccination.
引用
收藏
页码:9 / 26
页数:18
相关论文
共 144 条
[1]   Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens [J].
Ackerman, AL ;
Kyritsis, C ;
Tampé, R ;
Cresswell, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) :12889-12894
[2]   Human cytomegalovirus inhibits antigen presentation by a sequential multistep process [J].
Ahn, KS ;
Angulo, A ;
Ghazal, P ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10990-10995
[3]   DNA vaccination: Transfection and activation of dendritic cells as key events for immunity [J].
Akbari, O ;
Panjwani, N ;
Garcia, S ;
Tascon, R ;
Lowrie, D ;
Stockinger, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :169-177
[4]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[5]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[6]   Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells [J].
Allan, RS ;
Smith, CM ;
Belz, GT ;
van Lint, AL ;
Wakim, LM ;
Heath, WR ;
Carbone, FR .
SCIENCE, 2003, 301 (5641) :1925-1928
[7]  
Arnold-Schild D, 1999, J IMMUNOL, V162, P3757
[8]   Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8+ T cells by dendritic cells [J].
Arrode, G ;
Boccaccio, C ;
Lule, J ;
Allart, S ;
Moinard, N ;
Abastado, JP ;
Alam, A ;
Davrinche, C .
JOURNAL OF VIROLOGY, 2000, 74 (21) :10018-10024
[9]   Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology [J].
Asselin-Paturel, C ;
Boonstra, A ;
Dalod, M ;
Durand, I ;
Yessaad, N ;
Dezutter-Dambuyant, C ;
Vicari, A ;
O'Garra, A ;
Biron, C ;
Brière, F ;
Trinchieri, G .
NATURE IMMUNOLOGY, 2001, 2 (12) :1144-1150
[10]   Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8+ T cells [J].
Basta, S ;
Chen, WS ;
Bennink, JR ;
Yewdell, JW .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5403-5408